R. Manjunatha Kini
Corporate Officer/Principal presso National University of Singapore
Profilo
R.
Manjunatha Kini is the founder of ProTherapeutics Pte Ltd.
founded in 2005.
Currently, he is a Professor at the National University of Singapore.
Posizioni attive di R. Manjunatha Kini
| Società | Posizione | Inizio |
|---|---|---|
| National University of Singapore | Corporate Officer/Principal | - |
Precedenti posizioni note di R. Manjunatha Kini
| Società | Posizione | Fine |
|---|---|---|
ProTherapeutics Pte Ltd.
 ProTherapeutics Pte Ltd. BiotechnologyHealth Technology ProTherapeutics Pte Ltd. develops new drugs from proteins. It also offers bioactive peptides, which are derived from snake venom toxins and human proteins for tumor regression, macular degeneration, diabetic retinopathy, anti-hypertension, anti-inflammation, hypolocomotion effect, and clot initiation. The company was founded by Ruowen Ge, Peter Wong Tsun Hon, and R. Manjunatha Kini in April 2005 and is headquartered in Singapore. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
ProTherapeutics Pte Ltd.
ProTherapeutics Pte Ltd. BiotechnologyHealth Technology ProTherapeutics Pte Ltd. develops new drugs from proteins. It also offers bioactive peptides, which are derived from snake venom toxins and human proteins for tumor regression, macular degeneration, diabetic retinopathy, anti-hypertension, anti-inflammation, hypolocomotion effect, and clot initiation. The company was founded by Ruowen Ge, Peter Wong Tsun Hon, and R. Manjunatha Kini in April 2005 and is headquartered in Singapore. | Health Technology |
- Borsa valori
- Insiders
- R. Manjunatha Kini
